Tofacitinib (Xeljanx®) is now available on the Pharmaceutical Benefits Scheme (PBS) for those diagnosed with psoriatic arthritis.
On 1 March, 2019, ixekizumab (Taltz®), was added to the Pharmaceutical Benefits Scheme (PBS) to give adults with severe psoriatic arthritis more treatment options. Previously, Australian adults had been able to access the medication, but at a cost of around...
This steroid is commonly prescribed to help with RA flares. Here’s what you need to know before you start it.
A new study compared infection risks among different biologics for RA — and Orencia came out ahead.